Methyl-trioxymethylene
Methyl-trioxymethylene is a pharmaceutical compound primarily used in the treatment of severe respiratory conditions. It is known for its potent bronchodilator properties, which help alleviate symptoms associated with conditions such as chronic obstructive pulmonary disease (COPD) and severe asthma.Methyl-trioxymethylene is indicated for the relief of bronchospasm in patients with obstructive airway diseases, including COPD and asthma exacerbations. It is particularly useful in situations where conventional bronchodilators may not provide sufficient relief.
The dosage of Methyl-trioxymethylene varies depending on the severity of the condition and individual patient response. Typically, it is administered via inhalation as a mist or nebulized solution. The exact dosage should be determined by a healthcare provider based on the specific circumstances of the patient.
Methyl-trioxymethylene is contraindicated in patients with a known hypersensitivity to the drug or any of its components. It should not be used in patients with a history of severe cardiovascular disease, such as unstable angina or recent myocardial infarction, unless under strict medical supervision.
Special precautions should be taken when administering Methyl-trioxymethylene to patients with hypertension, hyperthyroidism, diabetes mellitus, or those prone to seizures. Caution is also advised in elderly patients and individuals with renal or hepatic impairment.
Common side-effects of Methyl-trioxymethylene include palpitations, tremors, headache, and nausea. Less frequently, it may cause paradoxical bronchospasm, which requires immediate discontinuation of the medication and medical intervention.
Methyl-trioxymethylene may interact with other sympathomimetic agents, monoamine oxidase inhibitors (MAOIs), and beta-blockers. Concurrent use with these medications should be closely monitored to avoid potential interactions and adverse effects.
| Brand Name | Manufactured by |
|---|---|
| SOLECROSS | CADILA PHARMACEUTICALS LTD. |
